Nathalie Amara Reilly

Nathalie Amara Reilly

Auto-generated profile, based on publicly available information

Nathalie Amara Reilly

Molecular Epidemiology, Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, the Netherlands; Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2021 in Nature Reviews Cardiology
Verified
Journal Article
Closed access
PDF file
NRNathalie A. Reilly
Nathalie A. Reilly
ELEsther Lutgens
Esther Lutgens
JKJohan Kuiper
Johan Kuiper
BHBastiaan T. Heijmans
Bastiaan T. Heijmans
JJJ. Wouter Jukema
J. Wouter Jukema

31 October 2024 in JACC: Basic To Translational Science
Verified
Journal Article
Open access
NRNathalie A. Reilly
Nathalie A. Reilly
KDKoen F. Dekkers
Koen F. Dekkers
JMJeroen Molenaar
Jeroen Molenaar
SASinthuja Arumugam
Sinthuja Arumugam
TKThomas B. Kuipers
Thomas B. Kuipers
BHBastiaan T. Heijmans
Bastiaan T. Heijmans
Twice-daily intake of purified eicosapentaenoic acid (EPA) reduces atherosclerotic cardiovascular disease risk in patients with high triglycerides, but its exact mechanism remains unclear. We exposed non-activated CD4+ T cells to 100μM EPA, oleic acid, palmitic acid, or control, and conducted RNA and ATAC-sequencing after 48 hours. EPA exposure downregulated immune response-related genes like HLA-DRA, CD69, and IL2RA, and upregulated oxidative stress prevention genes like NQO1. Transcription factor footprinting showed decreased GATA3 and PU.1, and increased REV-ERB. These effects were specific to EPA, suggesting it induces an anti-inflammatory transcriptomic landscape in CD4+ T cells, contributing to its observed cardiovascular benefits.

21 August 2025 in JACC: Basic To Translational Science
Verified
Journal Article
Open access
NRNathalie A. Reilly
Nathalie A. Reilly
JMJanneke W.C.M. Mulder
Janneke W.C.M. Mulder
KDKoen F. Dekkers
Koen F. Dekkers
TKThomas B. Kuipers
Thomas B. Kuipers
LZLeonie C. van Vark-Van der Zee
Leonie C. van Vark-Van der Zee
BHBastiaan T. Heijmans
Bastiaan T. Heijmans
Triglycerides and T cells play a key role in atherosclerosis, the leading cause of cardiovascular disease (CVD). Moderately elevated triglycerides have emerged as a causal risk factor, and T cells are a prominent component of atherosclerotic plaques. This cross-sectional study examined transcriptomic differences in T cells among patients with varying triglyceride levels via RNA sequencing. We analyzed CD4+ and CD8+ T cells from 49 participants, including those with primary (genetic) and secondary moderate hypertriglyceridemia, severe hypertriglyceridemia, and hypotriglyceridemia. Patients with primary moderate hypertriglyceridemia exhibited a proinflammatory transcriptomic profile, including increased interleukin-6 receptor (IL6R) expression, which is implicated in CVD risk. Similar patterns appeared in CD8+ T cells and, to a lesser extent, in secondary moderate hypertriglyceridemia patients. Conversely, transcriptomic differences were reversed in hypotriglyceridemia and absent in severe hypertriglyceridemia patients. These findings suggest that elevated triglycerides may contribute to CVD by promoting a proinflammatory transcriptomic profile in T cells.

21 February 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
NRNathalie A. Reilly
Nathalie A. Reilly
FSFriederike Sonnet
Friederike Sonnet
KDKoen F. Dekkers
Koen F. Dekkers
JKJoanneke C. Kwekkeboom
Joanneke C. Kwekkeboom
LSLucy Sinke
Lucy Sinke
BHBastiaan T. Heijmans
Bastiaan T. Heijmans
Summary: T cells are the most common immune cells in atherosclerotic plaques and the function of T cells can be altered by fatty acids. Here, we show that pre-exposure of CD4 + T cells to oleic acid, an abundant fatty acid linked to cardiovascular events, results in a preferential differentiation into pro-inflammatory subsets upon activation by upregulating core metabolic pathways. RNA-sequencing of non-activated CD4 + T cells revealed that oleic acid upregulates genes encoding enzymes responsible for cholesterol and fatty acid biosynthesis. Transcription footprint analysis linked this rewiring to the differentiation of pro-inflammatory subsets. Indeed, spectral flow cytometry showed that pre-exposure to oleic acid results in a skew toward IL-9, IL-17A, IL-5 and IL-13 producing T cells upon activation. Importantly, inhibition of either cholesterol or fatty acid biosynthesis abolishes this effect, suggesting a beneficial role for statins beyond cholesterol lowering. Taken together, fatty acids may affect inflammatory diseases by influencing T cell metabolism.

17 March 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
NRNathalie Amara Reilly
Nathalie Amara Reilly
KDKoen F. Dekkers
Koen F. Dekkers
JMJeroen Molenaar
Jeroen Molenaar
SASinthuja Arumugam
Sinthuja Arumugam
TKThomas B. Kuipers
Thomas B. Kuipers
BHBastiaan T. Heijmans
Bastiaan T. Heijmans
A twice-daily dose of highly purified eicosapentaenoic acid (EPA) reduces the risk of atherosclerotic cardiovascular disease among patients with high triglycerides and either known cardiovascular disease or those at high risk for developing it. However, the process by which EPA exerts its beneficial effects remains poorly understood. Here, we show that EPA can induce an anti-inflammatory transcriptional profile in non-activated CD4 + T cells. We find that EPA-exposed CD4 + T cells downregulate immune response related genes, such as HLA-DRA, CD69 , and IL2RA , while upregulating genes involved in oxidative stress prevention, such as NQO1 . Furthermore, transcription footprint analysis based on ATAC-sequencing reveals downregulation of GATA3 and PU.1, key transcription factors in T H 2 and T H 9 differentiation, and upregulation of REV-ERB, an antagonist of T H 17 differentiation. By in parallel examining T cell responses to oleic acid, a monounsaturated fatty acid, and palmitic acid, a saturated fatty acid, we find that both the intensity of the transcriptomic response and the involvement of anti-inflammatory pathways is highly specific for EPA. Thus, EPA can induce an anti-inflammatory transcriptomic landscape in CD4 + T cells, a process that may contribute to the unexpectedly strong beneficial effects of EPA on the risk of atherosclerotic cardiovascular disease in clinical trials.